We are Sorry, This Page doesn't Exist
Moderna just laid out its strategy to fight coronavirus variants and says a new shot is ready to be tested
Moderna shipped a new version of its coronavirus vaccine to the NIH so that it could be tested in people. A nurse prepares a shot of Moderna's COVID-19 vaccine. Hans P.....»»
Why grandparents can’t find vaccines: Scarcity of niche biotech ingredients
Limited supply of key ingredients called lipids has constrained coronavirus vaccine manufacturing and contributed to the frustratingly slow rollout of shots in the United States and Europe......»»
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet"s Spin-Off, IPO Deluge Hits Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scal.....»»
Johnson & Johnson Seeks US Emergency Approval For Single Dose COVID-19 Vaccine
Johnson & Johnson (NYSE: JNJ) said Wednesday that its subsidiary Janssen Biotech Inc is requesting approval from the United States Food and Drug Administration for its single-dose COVID-19 vaccine candidate. read more.....»»
The White House coronavirus testing czar says all Americans will have access to the vaccine by the end of June
The estimate is based on the two vaccines that have been approved, so the timeline could speed up as more vaccines get the green light. HHS Assistant Secretary Admiral Brett Giroir is pictured above on "Fox News Sunday" on December 27, 2020. .....»»
: AstraZeneca’s COVID-19 vaccine could be approved in U.K. ‘shortly after Christmas’ – top Oxford scientist says
Approval of AstraZeneca-Oxford University shot would come as the U.K. grapples with a new coronavirus strain that has triggered a wave of travel bans......»»
FedEx begins shipping second COVID-19 vaccine, with first Moderna shots expected Monday
FedEx began shipping the second coronavirus vaccine candidate to earn emergency authorization in the U.S. after Moderna, a Massachusetts-based biotech company, received the authorization for its vaccine candidate from an FDA advisory panel on Thursday......»»
Moderna"s groundbreaking coronavirus vaccine was designed in just 2 days
The biotech company designed its vaccine, which is highly effective, over two days in January - before many people had heard of the coronavirus. Mode.....»»
Trump is conspicuously absent from the list of public figures getting a coronavirus vaccine soon
Former presidents Barack Obama, George W. Bush, and Bill Clinton pledged to get the vaccine live on TV, as has vice president Mike Pence. Donald Trump on the South Lawn at the White House in Washington DC, on December 12, 2020. REUTERS/Cheriss M.....»»
Moving scenes show the first coronavirus vaccine in the US being administered to healthcare workers across the country
The FDA gave emergency use approval to the Pfizer-BioNTech vaccine last Friday. Batches of the vaccine were rolled out earlier this week. Vincent Kalut / Pho.....»»
: Moderna nears its first-ever FDA authorization, for its COVID-19 vaccine
If the Food and Drug Administration authorizes Moderna Inc.’s COVID-19 vaccine candidate, it will be the second vaccine made available to Americans during the coronavirus pandemic --- and the first-ever authorized product for the 10-year-old biotech......»»
The FDA will likely grant Moderna"s COVID-19 vaccine emergency use authorization on Friday
The US bought 200 million doses of Moderna's vaccine as of December 15, and has the option to buy 300 million more. A nurse prepares a coronavirus vaccine shot developed by th.....»»
Moderna COVID-19 vaccine has "favorable safety profile," FDA documents show, putting it closer to approval
The Food and Drug Administration released documents detailing Moderna's coronavirus vaccine candidate's "favorable safety profile" on Tuesday ahead of a key committee meeting scheduled for Thursday......»»
Biotech ETFs surge on vaccine rollout, Alexion-AstraZeneca tie-up
Biotech exchange-traded funds rallied Monday as the rollout of the coronavirus vaccine across America shed a bullish light on the industry. The First Trust NYSE Arca Biote.....»»
The coronavirus vaccine rollout has begun
These are Business Insider's biggest healthcare stories for December 14. Welcome to Business Insider's daily healthcare newsletter, your daily dose .....»»
IPO Outlook: Popular E-commerce Company Wish, Plus Offerings From A Personal Loan Disruptor And A Biotech Firm
After the huge IPOs from AirBnB Inc (NASDAQ: ABNB) and DoorDash Inc (NYSE: DASH) last week, the week of December 13 takes a slight breather with only three IPOs scheduled and one potential blockbuster. read more.....»»
The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) read more.....»»
Pfizer, BioNTech race to test vaccines
Pfizer's chief scientific officer tells Reuters his company got a head start on vaccine development for the coronavirus because it had already been working for two years on the flu with its German partner, BioNTech. Fred Katayama reports......»»
Moderna just sped up the timeline for testing its promising coronavirus vaccine. We got the inside story on how the biotech upstart developed the injection in record time.
Moderna The biotech Moderna developed a potential coronavirus vaccine in re.....»»
Moderna Announces FDA Nod For Phase 2 Coronavirus Vaccine Study, Hints At Approval In 2021
Moderna Inc (NASDAQ: MRNA) reported Thursday ahead of the market open with a first-quarter loss that came in line with expectations and also issued an update on its coronavirus vaccine .....»»